You may have attempted to lose weight and keep it off many times in the past. The ups and downs can certainly be difficult, but you may finally be able to lose weight and keep it off with the help of Wegovy™.
In a 68-week medical study of 1,961 adults living with obesity or excess weight with a related medical problema:
adults lost
on average
(or ~15% body weight)
while taking Wegovy™
In a 68-week medical study of 1,961 adults living with obesity or excess weight with a related medical problema:
aResults are from a 68-week medical study of adults with obesity (BMI ≥30) and adults who were excess weight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups were instructed to take the medicine along with a reduced-calorie meal plan and increased physical activity. 7% of people taking Wegovy™ (92 people) left the medical study due to side effects, compared to 3.1% of people taking placebo (20 people).
While not approved to treat these conditions, adults taking Wegovy™ experienced improvements ina:
Blood pressure | |
Cholesterol | |
Blood sugar |
Some people taking Wegovy™ also experienced an increase in resting heart rate.
Talk to your health care provider about how you could see benefits beyond the scale with Wegovy™
In a separate 68-week medical study, everyone started on Wegovy™ and were instructed to reduce calories and increase physical activity throughout the length of the study.
After 20 weeks, some people continued to take Wegovy™, while others switched to placebo. From weeks 20 to 68, people taking Wegovy™ continued to lose weight. People taking placebo gained weight.
A closer look at weight loss in a 68-week study:
bThis medical study included 902 adults with obesity (BMI ≥30) or excess weight (BMI ≥27) with at least one weight-related condition. People with type 2 diabetes were excluded. In the first 20 weeks, everyone started taking Wegovy™ and 803 people were able to reach the full dose. 5.8% of people taking Wegovy™ discontinued after week 20, compared to 11.6% for placebo.
Still have questions?
The free WeGoTogether™ personalized support program features: